Sign up
Quantellect · Congress · Trade Detail
RCPTReceptos, Inc. (RCPT) F ILINg S TATUS : New S UBHoLDINg o F : Thomas C MacArthur and Deborah A MacArthur
RepublicanHouse

Thomas MacArthur sold Receptos, Inc. (RCPT) F ILINg S TATUS : New S UBHoLDINg o F : Thomas C MacArthur and Deborah A MacArthur (RCPT)

Thomas MacArthur (R-NJ), a U.S. Representative, has disclosed 2 trades in Receptos, Inc. (RCPT) F ILINg S TATUS : New S UBHoLDINg o F : Thomas C MacArthur and Deborah A MacArthur (RCPT) since 2015, 1 purchase and 1 sale, worth an estimated $16K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a sale: Thomas MacArthur sold $1,001 - $15,000 of Receptos, Inc. (RCPT) F ILINg S TATUS : New S UBHoLDINg o F : Thomas C MacArthur and Deborah A MacArthur (RCPT) on May 27, 2015. Since that trade, RCPT is up +0.00% against the S&P 500 up +319.20%, an outperformance of -319.20%.

Across these filings, Thomas MacArthur has been a balanced trader of RCPT (a buy-to-sell ratio of 1.00). Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

RCPT trades
2
Disclosed Vol
$16K
Buys
1
50%
Sells
1
50%
Buy / Sell
1.00
ratio
First → Last
2015

Thomas MacArthur's RCPT trades vs the price

RCPT is up +0.00% since Thomas MacArthur sold on May 27, 2015, versus +319.20% for the S&P 500.

Performance since this trade

Price change since trade
+0.00%
S&P 500 change since trade
+319.20%
Outperformance vs S&P 500
-319.20%

All Thomas MacArthur RCPT trades

TradedTypeSizeReturnEst. profit
May 27, 2015SELL$1,001 - $15,000N/A
May 26, 2015BUY$1,001 - $15,000N/A

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

Thomas MacArthur & RCPT trading FAQ

Is it legal for Thomas MacArthur to trade Receptos, Inc. (RCPT) F ILINg S TATUS : New S UBHoLDINg o F : Thomas C MacArthur and Deborah A MacArthur (RCPT) stock?

Yes. Members of Congress are allowed to trade individual stocks, including Receptos, Inc. (RCPT) F ILINg S TATUS : New S UBHoLDINg o F : Thomas C MacArthur and Deborah A MacArthur (RCPT), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did Thomas MacArthur sell RCPT?

Thomas MacArthur disclosed a sale of $1,001 - $15,000 of Receptos, Inc. (RCPT) F ILINg S TATUS : New S UBHoLDINg o F : Thomas C MacArthur and Deborah A MacArthur (RCPT) on May 27, 2015, according to public STOCK Act filings.

How has RCPT performed since Thomas MacArthur's trade?

Since Thomas MacArthur sold RCPT on May 27, 2015, the stock is up +0.00%, versus +319.20% for the S&P 500 over the same period, an outperformance of -319.20%.

How many times has Thomas MacArthur traded RCPT?

Thomas MacArthur has disclosed 2 RCPT trades since 2015 (1 purchase and 1 sale). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional RCPT trades?

Quantellect tracks every disclosed congressional trade in Receptos, Inc. (RCPT) F ILINg S TATUS : New S UBHoLDINg o F : Thomas C MacArthur and Deborah A MacArthur (RCPT) on the Receptos, Inc. (RCPT) F ILINg S TATUS : New S UBHoLDINg o F : Thomas C MacArthur and Deborah A MacArthur congressional trading page, which aggregates filings across all members of Congress.

Thomas MacArthur's RCPT tradesAll congressional filings for Receptos, Inc. (RCPT) F ILINg S TATUS : New S UBHoLDINg o F : Thomas C MacArthur and Deborah A MacArthurThomas MacArthur's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.